I have found the following academic papers thought provoking and stimulating. Some are open access, others are paywalled. I will add more here as I discover them - Suggestions for further reading welcome.
Smigielski, L., Kometer, M., Scheidegger, M. et al.
“Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat.”
Sci Rep 9, 14914 (2019). https://doi.org/10.1038/s41598-019-50612-3
Azmoodeh, K., Thomas, E., & Kamboj, S. K.
“Meditation trips: A thematic analysis of the combined naturalistic use of psychedelics with meditation practices.”
Experimental and Clinical Psychopharmacology, 31(3), (2023) 756–767. https://doi.org/10.1037/pha0000617
McAlpine, Rosalind, Merve Utanğaç, Joanna Kuc, Henok Pankhurst, Amelia Sellers, Doug Kraft, Andrew Litchy, et al.
“Practitioner Perspectives on Meditation-based Preparation for Psychedelic Experiences”.
PsyArXiv, February 6, 2025.
Simonsson, Otto, Walter Osika, Cecilia U. D. Stenfors, Simon B. Goldberg, Ludwig Honk, and Peter S. Hendricks.
“Longitudinal Associations between Psychedelic Use and Meditation Practices in the United States and the United Kingdom.”
Psychological Medicine 54, no. 6 (2024): 1228–34. https://doi.org/10.1017/S0033291723003082.
Kamboj SK, Kilford EJ, Minchin S, et al.
“Recreational 3,4-methylenedioxy-N-methylamphetamine (MDMA) or ‘ecstasy’ and self-focused compassion: Preliminary steps in the development of a therapeutic psychopharmacology of contemplative practices.”
Journal of Psychopharmacology. 2015;29(9):961-970.
Palitsky R, Canby ,Nicholas K., Van Dam ,Nicholas T., Levin-Aspenson ,Holly F., Kaplan ,Deanna M., Maples-Keller ,Jessica, et al.
“Leveraging meditation research for the study of psychedelic-related adverse effects.”
International Review of Psychiatry. 2024 Nov 16;36(8):841–55.
https://doi.org/10.1080/09540261.2024.2420745
Simonsson O, Chaturvedi S, Hendricks PS, Stenfors CUD, Osika W, Narayanan J, et al.
“Associations between psychedelic-related and meditation-related variables: A longitudinal study.”
Journal of Psychiatric Research. 2025 Apr 1;184:457–63.
https://doi.org/10.1016/j.jpsychires.2025.03.025
Moujaes F, Rieser NM, Phillips C, de Matos NMP, Brügger M, Dürler P, et al.
“Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation.”
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. 2024 May 1;9(5):533–43.
https://doi.org/10.1016/j.bpsc.2023.07.003
Dines JT.
“Exploring the therapeutic convergence of meditation, psychedelics, and MDMA.”
Journal of Psychedelic Studies [Internet]. 2025 Apr 17
Jiwani Z, Goldberg SB, Stroud J, Young J, Curtin J, Dunne JD, et al.
“Can psychedelic use benefit meditation practice? Examining individual, psychedelic, and meditation-related factors. “
PLOS ONE. 2025 Feb 12;20(2):e0310160.
https://doi.org/10.1371/journal.pone.0310160
Millière R, Carhart-Harris RL, Roseman L, Trautwein FM, Berkovich-Ohana A.
“Psychedelics, Meditation, and Self-Consciousness.”
Front Psychol [Internet]. 2018 Sept 4;9.https://www.frontiersin.orghttps://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2018.01475/full
Holas P, Kamińska J.
“Mindfulness meditation and psychedelics: potential synergies and commonalities.”
Pharmacol Rep. 2023;75(6):1398–409.
https://link.springer.com/article/10.1007/s43440-023-00551-8